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such as AKT, can phosphorylate Mdm2 and increase itsCyclin G: A Regulator
ability to target p53 (Michael and Oren, 2002). Therefore,of the p53-Mdm2 Network the activity of Mdm2 appears to be regulated by phos-
phorylation in a manner similar to that of cyclin-depen-
dent kinases (CDKs).
Cyclin G was one of the earliest p53 target genes to
A recent study published in the April issue of Molecular be identified, but its function in the p53 pathway has
Cell has shown that cyclin G, a p53 target, is a regula- been elusive (Okamoto and Beach, 1994). A number of
tory component of the active PP2A holoenzyme, which studies have shown that cyclin G has growth-promoting
activates Mdm2 through dephosphorylation. These functions and is highly expressed in regenerating hepa-
findings suggest that cyclin G is a key regulator of the tocytes and motoneurons and in rapidly growing cancer
p53-Mdm2 network. cells (Morita et al., 1996; Skotzko et al., 1995). In addition,
cyclin G can also increase the sensitivity of cancer cells
p53 is a stress sensor and is activated in response to to TNF-induced apoptosis (Okamoto and Prives, 1999).
a variety of stress stimuli. Activated p53 then regulates As a cyclin, cyclin G can associate with cdk5 and GAK,
a diverse array of target genes, which mediate p53 activ- a cyclin G-associated kinase (Kanaoka et al., 1997), but
ity in the control of cell cycle arrest, apoptosis, and DNA the significance of these associations is unclear. Cyclin
repair (Ko and Prives, 1996). Many cellular genes have G was also known to interact with the B subclass of
been identified, including p21, 14-3-3, and MCG10, PP2A phosphatase (Okamoto et al., 1996). PP2A is a
which induce cell cycle arrest; Bax, Puma, and Killer/ serine/threonine phosphatase, consisting of a catalytic
Dr5, which induce apoptosis; and p53R2 and GADD45, (C), a structural (A), and a regulatory (B) subunit. Until
which participate in DNA repair. However, after stress the recent Okamoto et al. study, the significance of the
subsides and cellular damage such as damaged DNA cyclin G-PP2A interaction was also not clear. Their new
is repaired, the activated p53 becomes harmful to nor- data have provided convincing evidence that cyclin G
mal cell growth and needs to be eliminated. It has been interacts with the enzymatically active PP2A phospha-
clearly demonstrated that the main negative regulator tase (Okamoto et al., 2002). In addition, cyclin G directly
of p53 is Mdm2, which is itself a p53 target gene (Michael interacts with Mdm2 and can stimulate the ability of
and Oren, 2002). PP2A to dephosphorylate Mdm2, and thus serves as
In response to various stress conditions, stress ki- a recruitment factor. Specifically, they provide strong
nases such as ATM are activated, which then phosphor- evidence that the PP2A holoenzyme is capable of de-
ylate and activate p53 (see Figure). Recent studies have phosphorylating two sites in Mdm2 (S166 and T216)
shown that some of these stress kinases also phosphor- both in vitro and in vivo.
ylate Mdm2, and phosphorylated Mdm2 has a reduced These data raise an important question: does cyclin
ability to interact with, and inhibit, p53 (Michael and G have an impact on the activity of Mdm2 toward p53?
Oren, 2002). Therefore, removal of an inhibitory phos- Using mouse embryo fibroblasts (MEF) that are deficient
phate from Mdm2 is necessary for its activation. In addi- in cyclin G, Prives and colleagues provide the most
interesting and compelling evidence that in the absencetion, recent evidence indicates that prosurvival kinases,
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in Mdm2 that are specifically targeted by cyclin G-PP2A?
Does cyclin G-PP2A, through dephosphorylation, acti-
vate MdmX, which is a member of the Mdm family (Mi-
chael and Oren, 2002) and a regulator of the p53-Mdm2
network? What are other cellular proteins that interact
with cyclin G and are also a substrate for cyclin G-PP2A?
Do cyclin G-cdk5 and cyclin G-GAK serve as a kinase
to phosphorylate Mdm2 and activate Mdm2 to inhibit
p53? Why do cyclin G null mice develop normally (Ki-
mura et al., 2001)? Do cyclin G-related cyclins, that is,
cyclin G2 and cyclin I, have similar activity? Is cyclin
G-PP2A phosphatase activity necessary for sensitizing
cancer cells to TNF-induced apoptosis? Finally, the
new findings raise the possibility that cyclin G could
be exploited for the development of cancer therapeutic
agents. For example, potential strategies could include
inhibition of cyclin G expression, blocking the interaction
of cyclin G with the B subunit of PP2A and Mdm2, and
inhibition of PP2A phosphatase activity toward Mdm2.
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(1995). Cancer Res. 55, 5493–5498.future. For example, what are the phosphorylation sites
upon the Z ring, so the problem of how the cell positionsUnexpected Twist to the Z Ring
the division site can be reduced to how the Z ring is
positioned (Lutkenhaus and Addinall, 1997). The devel-
opmental program in Bacillus subtilis that results in spor-
ulation offers a unique window on this problem. During
Development in Bacillus subtilis involves a switch in vegetative growth, the Z ring is positioned at midcell and
the location of the cytokinetic Z ring from midcell to the two equal-sized progeny cells are produced. However,
pole. Time lapse photography of an FtsZ-GFP fusion during sporulation, an alternative, asymmetric form of
reveals that this switch involves a spiral intermediate cell division is induced by nutrient deprivation, yielding
and allows identification of the specific sporulation two cells of different sizes, the forespore and the mother
functions involved. cell, with different developmental fates. A few years ago
it was demonstrated by immunofluorescence that Z
The Z ring is a cytoskeletal structure formed by the self- rings form at each cell pole early in sporulation (Levin
assembly of FtsZ, the ancestral homolog of eukaryotic and Losick, 1996). One of these is used for the asymmet-
ric division, while the other is eventually discarded.tubulins. In most prokaryotes, cell division depends
